Michael Lechner

Michael Lechner is a medical specialist and researcher at the University Clinic for Surgery, affiliated with Paracelsus Medical University in Salzburg, Austria. He holds the academic title of Privatdozent and is actively engaged in clinical and academic surgical research, particularly in hernia surgery, gastrointestinal oncology, and perioperative risk assessment.

• University: Paracelsus Medical University
• School: Faculty of Medicine
• Department: Department of Surgery
• Email: m.lechner@salk.at

His research interests include surgical oncology, hernia repair (especially inguinal and Bochdalek hernias), minimally invasive techniques, postoperative complications, and the use of prognostic models such as the GSU-Pulmonary Score to predict surgical outcomes. He has explored innovative applications of botulinum toxin in managing complex hernias.

The recent publication trends show a strong focus on case reports, systematic reviews, and original research in high-impact surgical journals like Hernia and European Surgery. His work often involves international collaborations and contributes to evidence-based surgical guidelines.

• A prognostic model for postoperative pulmonary complications (2024)
• Management of giant scrotal hernias using botulinum toxin (2025)
• Systematic review on adult right-sided Bochdalek hernias (2022)
• Clip migration after hemicolectomy (2025)

Dr. Lechner is actively involved in academic and professional development through organizing and participating in surgical workshops and symposia. He has co-organized multiple Hernia Workshops (2018–2019) and served on the Scientific Advisory Board for the Salzburg Symposium on Thoracic Surgery 2024, demonstrating leadership in continuing medical education and knowledge dissemination within the surgical community.